Member Spotlight: 2025 Year in Review
As we say goodbye to 2025, Bio Nebraska takes a look back at the organizations featured throughout the past year in our monthly Member Spotlight series.
Member Spotlight: Celerion
For our November Member Spotlight, we’re featuring Celerion, a global leader in early clinical research and bioanalytical services.
Member Spotlight: ADS Biotec
For our October Member Spotlight, we talked to ADS Biotec, this year’s Governor’s Bioscience Award Winner.
Member Spotlight: RespirAI
For our September Member Spotlight, we talked to RespirAI, an AI-powered monitoring platform that provides continuous, remote assessment of respiratory health.
Member Spotlight: McCarthy
For our August Member Spotlight, we caught up with McCarthy, a local contractor with national resources fueled by a passion for building and a commitment to doing quality work.
Member Spotlight: Docology
For our July Member Spotlight, we spoke with Docology, a company working to support medical professionals by alleviating their administrative burdens.
Member Spotlight: Metropolitan Community College
For our June Member Spotlight, we spoke with Metropolitan Community College (MCC), the second-largest postsecondary institution in Nebraska, about their new biotechnology program, set to launch in fall 2026.
Member Spotlight: BWBR
For our May Member Spotlight, we spoke with BWBR, a design solutions firm with a diverse practice in architecture, interior design, and master/strategic/facility planning.
Member Spotlight: Streck
For our April Member Spotlight, we spoke with Streck about how they support clinical and research laboratories around the world, with the goal of creating a safer, healthier, and more productive world.
Member Spotlight: SoDak Solutions
For our March Member Spotlight we talked to SoDak Solutions, a consulting service founded in 2023 by Ron Utecht and Barb Haberer that specializes in guiding visionaries through the journey from early-stage research to product development in the fields of biotechnology, medical devices, and drug development.